News | June 04, 2026
Novo Nordisk launches Wegovy pill in UAE in first global rollout outside US
The move signals a major expansion in access to next-generation weight-loss therapies
The move signals a major expansion in access to next-generation weight-loss therapies
Specialised clinic to offer regular device monitoring, battery assessment, rhythm evaluation, and expert cardiac electrophysiology consultation
The industry is expected to grow significantly over the next few years as healthcare accessibility improves and insurance penetration increases
DCGI-approved semaglutide syringes for diabetes and obesity expand treatment choices and improve affordability
First-in-class treatment of life-threatening, drug-resistant Acinetobacter baumannii infections advancing toward Phase II clinical proof-of-concept
New PARTNER trial sub-study data show that post-operative ctDNA detection using tumour-informed MRD assays can accurately predict distant recurrence risk in triple-negative breast cancer patients
The hospital successfully treats two complex high-risk cardiac patients using advanced minimally invasive heart surgeries
The approval is expected to support the company’s presence in regulated international markets and further strengthen its position as a reliable pharma manufacturing partner
The filing is backed by Phase III data from the lidERA Breast Cancer study
The companies say the drug has now demonstrated clinical benefit in three separate Phase 3 trials
Subscribe To Our Newsletter & Stay Updated
